Melanoma tag sponsored by:
Melanoma
-
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1 / IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting - San Francisco Biotechnology Network | Bay Area Li
sfbn.org | | Article Details | Related Articles